Median-based incremental cost-effectiveness ratios with censored data. Academic Article uri icon

abstract

  • Cost-effectiveness is an essential part of treatment evaluation, in addition to effectiveness. In the cost-effectiveness analysis, a measure called the incremental cost-effectiveness ratio (ICER) is widely utilized, and the mean cost and the mean (quality-adjusted) life years have served as norms to summarize cost and effectiveness for a study population. Recently, the median-based ICER was proposed for complementary or sensitivity analysis purposes. In this article, we extend this method when some data are censored.

published proceedings

  • J Biopharm Stat

author list (cited authors)

  • Bang, H., & Zhao, H.

citation count

  • 6

complete list of authors

  • Bang, Heejung||Zhao, Hongwei

publication date

  • May 2016